1. Alberts DS, Peng Y-M, Moon TE, Bressler R. Carnitine prevention of adriamycin toxicity in mice. Biomedicine 1978;29:265–8.
2. Judy WV, Hall JH, Dugan W, et al. Coenzyme Q10 reduction of Adriamycin® cardiotoxicity. In Biomedical and Clinical Aspects of Coenzyme Q, vol. 4, ed. K Folkers, Y Yamamura. Amsterdam: Elsevier/North Holland Biomedical Press, 1984, 231–41.
3. Ogura R, Toyama H, Shimada T, Murakami M. The role of ubiquinone (coenzyme Q10) in preventing Adriamycin®-induced mitochondrial disorders in rat heart. J Appl Biochem 1979;1:325.
4. Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer 1999;35:1688–92.
5. Doroshow JH, Locker GY, Ifrim I, et al. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest 1981;68:1053–64.
6. Meyers C, Bonow R, Palmeri S, et al. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol 1983;10:53–5.
7. Pinto J, Raiczyk GB, Huang YP, Rivlin RS. New approaches to the possible prevention of side effects of chemotherapy by nutrition. Cancer 1986;58:1911–4.
8. Fujita K, Shinpo K, Yamada K, et al. Reduction of Adriamycin® toxicity by ascorbate in mice and guinea pigs. Cancer Res 1982;42:309–16.
9. Myers C, McQuire W, Young R. Adriamycin® amelioration of toxicity by alpha-tocopherol. Cancer Treat Rep 1976;60:961–2.
10. Sonneveld P. Effect of alpha-tocopherol on the cardiotoxicity of Adriamycin® in the rat. Cancer 1978;62:1033–6.
11. Ripoll EAP, Rama BN, Webber MM. Vitamin E enhances the chemotherapeutic effects of Adriamycin® on human prostatic carcinoma cells in vitro. J Urol 1986;136:529–31.
12. Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treatment Rev 1997;23:209–40 [review].
13. Wood LA. Possible prevention of Adriamycin®-induced allopecia by tocopherol. N Engl J Med 1985;312:1060 [letter].
14. Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treatment Rev 1997;23:209–40 [review].
May Be Beneficial: Depletion or interference—This medication may deplete these substances from the body or interfere with how they work; extra intake may help replenish them.
Avoid: Reduces drug effectiveness—When taking this medication, avoid these substances as they may decrease the medication's absorption and/or activity in the body.
Check: Explanation needed—When taking this medication, read the article details and discuss them with your doctor or pharmacist before taking these substances.